Baking soda "hungry" dead cancer cells, the truth is actually like this September 26, 2016 Source: Xinhuanet In the past two days, has your circle of friends been screened by this news? "Major breakthrough! Cancer cells have been "hungry" by Chinese doctors with baking soda." The reporter collected the top eight topics for discussion. He once again talked to Changjiang Scholar, Professor of the Institute of Cancer Research of Zhejiang University, and Professor Yan Ming of the Institute of Radiology, the Second Affiliated Hospital of Zhejiang University School of Medicine, hoping to answer questions from friends who are concerned about the research results. [Question 1] Is baking soda "hungry" dead cancer cells equal to drinking soda water to fight cancer and prevent cancer? TILA-TACE, an innovative treatment developed by two expert teams (targeting intra-arterial lactate anion and hydrogen ion insertion) Tube Chemoembolization) How does the medium and small soda enter the body? Does the injection, medication or by what means on the tumor? Yan Ming: It is recognized that drinking alkaline water is good for health, but there is no accurate scientific basis for the problem of "soda water anti-cancer effect". The way we use it is to inject sodium bicarbonate into the tumor through the tumor nourishing blood vessels and change the pH inside the tumor. The use of a base such as sodium bicarbonate (baking soda) to remove hydrogen ions from the tumor destroys the synergistic effect of lactate and hydrogen ions, thereby rapidly and effectively killing tumor cells that are starved or deficient in glucose. How the scientific principles are implemented in the human body requires repeated verification. This is a preliminary study, but the results are real. [Question 2] TILA-TACE is currently effective in primary hepatocellular carcinoma. Is the applicability to other cancers also under study? Yan Ming: At present, our research is aimed at the treatment of primary hepatocellular carcinoma. But this principle is universal for most solid tumors. Tumors grow in different locations, and their blood supply conditions and embolization need to be considered. For example, brain tumors are not suitable for cTACE (traditional arterial intubation chemotherapy embolization), and embolism can cause serious complications. Although the preliminary results of the study are encouraging, more in-depth research is needed. One study has its marginal effects and can be applied to other cancers with advancement. [Question 3] Which patients can receive TILA-TACE treatment? Yan Ming: Our clinical trials range from advanced hepatocellular carcinoma to advanced hepatocellular carcinoma. This definition of the mid-term and late stage is not the middle and late stage of time that is often mentioned in the mouth of the common people. It has strict medical standards: the mid-term of the tumor is greater than 3 cm; the vascular invasion of the tumor is the late stage. For some end-stage patients who have had ascites and jaundice, we regret that we have not made a breakthrough. [Question 4] Is the current treatment effect on primary hepatocellular carcinoma effective or is it cured? Yan Ming: "Effective" means the judgment of the response to this treatment. The extent to which the reaction is called "effective" has different criteria. For example, the RECIST standard is to observe changes in tumor size. The EASL standard was used in our study to observe the necrosis rate of tumors. More than 50% of necrosis is "effective." Our objective response rate for treating tumors is 100%, so it is called "effective." Hu Wei: In addition to questioning the number of 40 cases in clinical trials, we want to say that this research is a frontier study. The number of cases is unlikely to be many. We hope to play a role in “bringing bricks and attracting jade†and its immature nature. The results of the published paper are the results of the treatment of patients enrolled in strict conditions, and more research is needed to prove the accuracy. [Question 5] Baking soda and cTACE, which are the key to treatment? Who is the "main dish" and who is "chili powder"? Hu Wei: cTACE was proposed by Japanese scholars in the 1970s. It has been 40 years since it was clinically proven to be effective, but its bottleneck is not high enough, especially for advanced liver cancer. TILA-TACE has a little cosmetic on the surface, but it has a profound background in tumor biology, introduces a new mechanism of tumor death, solves the problem of scientific theory, and then translates into clinical practice. on. If scientifically repeated verification confirms the efficacy of TILA-TACE, it is possible to replace the current cTACE procedure, so that more patients get better treatment, which is the significance of the research. Yan Ming: A lot of basic research stays in the laboratory and it is difficult to switch to clinical practice. From theory to practice is a difficult leap. Improvement is a technical issue, and innovation is a scientific issue. TILA-TACE is not an improvement, but an innovation. It uses technology to promote the development of technology. It is not appropriate to use chili powder as a metaphor. [Question 6] Will it have more side effects like chemotherapy, such as hair loss, vomiting, etc? Yan Ming: Because of the local chemotherapy, the chemotherapy response is very low, far less than systemic chemotherapy. Primary hepatocellular carcinoma rarely uses systemic chemotherapy because of poor efficacy and patient intolerance. The study has not yet terminated, and the difference in efficacy between chemotherapy and non-chemotherapeutic drugs is currently being studied in a randomized controlled trial. The next step is to reduce the side effects of chemotherapy. [Question 7] What is the estimated cost of treatment after maturity? Yan Ming: Improving the efficacy reduces the number of repeated treatments, and the overall medical expenses will definitely be reduced. Larger liver cancer tumors may require many rounds of cTACE, but TILA-TACE improves the effectiveness of treatment and can reduce the number of treatments, thereby reducing overall treatment costs. Baking soda is a very cheap drug that does not increase the cost of the original base cTACE. According to the preliminary results, the relative treatment effect calculated by the tumor residual rate is increased by 80%. [Question 8] What is the evaluation of the international medical community? What is the international academic status of eLife? Hu Wei: eLife is a relatively new magazine. It was founded by the Howard Hughes Medical Research Institute, the Max Planck Society of Germany, and the Wellcome Trust of the United Kingdom. The editor is Nobel Prize winner Randy Schekman, 20 senior editors. There are 10 members of the American Academy of Sciences, and the two editors who reviewed this paper are internationally renowned scholars. Yan Ming: Science is actually the thickness of a layer of paper. The scientific reason is very simple, but the process of discovery is very difficult. The two of us have the same idea in research, and believe that cancer researchers need to adhere to two concepts - one is the original theoretical breakthrough, and the other is good for the patient. We do not pursue speed, we just want to explore the truth of science. For some free debates, this is normal, and it is also beneficial to promote development and to falsify the truth. Hu Wei: Our research, we believe that represents a new concept of treating tumors, has theoretical significance. Primary hepatocellular carcinoma is the best model to test this idea. We have broken through the bottleneck of poor liver cancer. This is an improvement, but it is still far from the ultimate goal. It requires our generation and even the next generation to persevere. Work hard. Buckwheat Noodle,Homemade Buckwheat Soba Noodles,Organic Food Buckwheat Fine Noodle,Buckwheat Noodles Healthy Huantai Biotechnology Co., Ltd. , https://www.huantaifds.com
Baking soda "hungry" dead cancer cells, the truth is actually like this